TSE CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83,200 KRW | +6.26% |
|
+52.94% | +68.25% |
| 04-29 | B.Duck Semk CFO Steps Down, Successor Named | MT |
| 04-10 | Scandinavian ChemoTech Secures Patent Protection in India | MT |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- With a 2024 P/E ratio at 28.93 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Semiconductor Equipment & Testing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +68.25% | 642M | - | ||
| +14.58% | 92.81B | B- | ||
| +7.03% | 23.42B | A- | ||
| +9.85% | 19.82B | C+ | ||
| +4.79% | 17.79B | B- | ||
| -9.26% | 4.39B | D | ||
| -3.87% | 3.63B | D | ||
| +12.84% | 3.59B | C+ | ||
| -22.74% | 2.54B | D- | ||
| -7.72% | 1.1B | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- A131290 Stock
- Ratings TSE Co., Ltd
